Search
Now showing items 1-10 of 19
Use of Cumulative Incidence of Novel Influenza A/H1N1 in Foreign Travelers to Estimate Lower Bounds on Cumulative Incidence in Mexico
(Public Library of Science, 2009)
Background: An accurate estimate of the total number of cases and severity of illness of an emerging infectious disease is required both to define the burden of the epidemic and to determine the severity of disease. When ...
Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009
(BioMed Central, 2010)
Background: During an influenza pandemic, a substantial proportion of transmission is thought to occur in households. We used data on influenza progression in individuals and their contacts collected by the City of Milwaukee ...
What is the Mechanism for Persistent Coexistence of Drug-susceptible and Drug-resistant Strains of Streptococcus pneumoniae?
(The Royal Society, 2009)
The rise of antimicrobial resistance in many pathogens presents a major challenge to the treatment and control of infectious diseases. Furthermore, the observation that drug-resistant strains have risen to substantial ...
Student Behavior during a School Closure Caused by Pandemic Influenza A/H1N1
(Public Library of Science, 2010)
Background: Many schools were temporarily closed in response to outbreaks of the recently emerged pandemic influenza A/H1N1 virus. The effectiveness of closing schools to reduce transmission depends largely on student/family ...
Vaccine Allocation in a Declining Epidemic
(The Royal Society, 2012)
Sizeable quantities of 2009 pandemic influenza A/H1N1 (H1N1pdm) vaccine in the USA became available at the end of 2009 when the autumn wave of the epidemic was declining. At that point, risk factors for H1N1-related mortality ...
Examining the role of different age groups, and of vaccination during the 2012 Minnesota pertussis outbreak
(Nature Publishing Group, 2015)
There is limited information on the roles of different age groups during pertussis outbreaks. Little is known about vaccine effectiveness against pertussis infection (both clinically apparent and subclinical), which is ...
Pre-dispensing of antivirals to high-risk individuals in an influenza pandemic
(Wiley-Blackwell, 2010)
We consider the net benefits of pre-dispensing antivirals to high-risk individuals during an influenza pandemic, where the measure of the benefit is the number of severe outcomes (such as deaths or hospitalizations) prevented ...
Predicting the Epidemic Sizes of Influenza A/H1N1, A/H3N2, and B: A Statistical Method
(Public Library of Science (PLoS), 2011)
BACKGROUND: The epidemic sizes of influenza A/H3N2, A/H1N1, and B infections vary from year to year in the United States. We use publicly available US Centers for Disease Control (CDC) influenza surveillance data between ...
Utilizing Syndromic Surveillance Data for Estimating Levels of Influenza Circulation
(Oxford University Press (OUP), 2014)
The availability of weekly Web-based participatory surveillance data on self-reported influenza-like illness (ILI), defined here as self-reported fever and cough/sore throat, over several influenza seasons allows for ...
Estimating the hospitalization burden associated with influenza and respiratory syncytial virus in New York City, 2003–2011
(John Wiley & Sons, Ltd, 2015)
Background: Hospitalization burden associated with influenza and respiratory syncytial virus (RSV) is uncertain due to ambiguity in the inference methodologies employed for its estimation. Objectives: Utilization of a new ...